Synapse - Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)

Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM) Meeting Abstract

Authors:	Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Shah, G. L.; Shouval, R.; Hashmi, H.; Hassoun, H.; Maclachlan, K. H.; Hultcrantz, M.; Korde, N.; Lesokhin, A. M.; Shah, U. A.; Tan, C. R.; Giralt, S. A.; Usmani, S. Z.; Rajeeve, S.
Abstract Title:	Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
Meeting Title:	66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	144
Issue:	Suppl. 1
Meeting Dates:	2024 Dec 7-10
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2024-11-05
Start Page:	1944
Language:	English
ACCESSION:	WOS:001411747900018
DOI:	10.1182/blood-2024-208490
PROVIDER:	wos
Notes:	Source: Wos